Reducing residual thrombotic risk in patients with peripheral artery disease: impact of the COMPASS trial

Patients with peripheral artery disease (PAD) are at a high risk not only for the classical cardiovascular (CV) outcomes (major adverse cardiovascular events; MACE) but also for vascular limb events (major adverse limb events; MALE). Therefore, a comprehensive approach for these patients should incl...

Descripción completa

Detalles Bibliográficos
Autores principales: Hernández, José Luis, Lozano, Francisco S, Riambau, Vincent, Almendro-Delia, Manuel, Cosín-Sales, Juan, Bellmunt-Montoya, Sergi, Garcia-Alegria, Javier, Garcia-Moll, Xavier, Gomez-Doblas, Juan José, Gonzalez-Juanatey, José R, Suarez Fernández, Carmen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioExcel Publishing Ltd 2020
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7357685/
https://www.ncbi.nlm.nih.gov/pubmed/32699549
http://dx.doi.org/10.7573/dic.2020-5-5

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7357685/
https://www.ncbi.nlm.nih.gov/pubmed/32699549
http://dx.doi.org/10.7573/dic.2020-5-5

Ejemplares similares